下列氨基酸在pH=4.0的溶液中，以负离子形式存在的是

【名词&注释】

相互关系(relationship)、辩证关系(dialectical relationship)、农村改革发展(countryside reform and development)、有限责任(limited liability)、人与自然关系(relationship between man and nature)、人与自然的关系(the relationship between man and nature)、推进改革(advancing reforms)、社会全面进步(overall social development)、必然结果(inevitable result)、资本集中(concentration of capital)

[单选题]下列氨基酸在pH=4.0的溶液中，以负离子形式存在的是

A. 谷氨酸
B. 甘氨酸
C. 丙氨酸
D. 赖氨酸

查看答案&解析查看所有试题

学习资料：

[多选题]右边这幅漫画对于我们认识人与自然关系的警示意义在于

A. 人类过分陶醉于对自然界的胜利将受到自然界的报复
B. 人与自然关系的紧张来自于不当的人类实践方式
C. 人与自然的关系本质上是对立的
D. 人类依附于自然是摆脱自身困境的根本出路

[多选题]下列选项中，应当以单位犯罪处罚的有（）

A. 某国有公司明知他人进行走私，为其提供贷款的
B. 某有限责任公司领导层为了单位利益，集体决定走私假币的
C. 自然人投资设立有限责任公司后，该公司以实施走私为主要活动的
D. 自然人以走私石油为目的注册有限责任公司后，该公司大量走私石油的

[单选题]吸人性肺脓肿最常见的部位是

A. 左上叶后段和舌叶 B．左下叶基底段 ．
B. 右上叶后段和下叶背段 D．右下叶基底段
C. 右中叶

[单选题]“风定花犹落，鸟鸣山更幽”形象地表达了动和静的辩证关系是（ ）

A. 静不是动，动不是静
B. 静中有动，动中有静
C. 动是必然的，静是偶然的
D. 动是静的原因，静是动的结果

[单选题]In the last paragraph ,a problem commercial genetic testing faces is

A. disorganized data collection.
B. overlapping database building.
C. excessive sample comparison.
D. lack of patent evaluation.

[多选题]党的十七届三中全会对当前和今后一个时期推进农村改革发展作出了部署，强调要今后农村改革发展的丁作布局是

A. 大力推进改革^{(advancing reforms)}创新，加强农村制度建设
B. 积极发展现代农业，提高农业综合生产能力
C. 加快发展农村公共事业，促进农村社会全面进步^{(overall social development)}
D. 坚持工业反哺农业、城市支持农村和多予少取放活方针

[多选题]资本积累、资本积聚和资本集中^{(concentration of capital)}的相互关系是（ ）

A. 资本集中^{(concentration of capital)}是资本积累的直接结果
B. 资本积聚是资本积累的必然结果^{(inevitable result)}
C. 资本积聚有利于资本集中^{(concentration of capital)}
D. 资本积聚和资本集中^{(concentration of capital)}是资本积累的两种形式

[单选题]根据下面材料，回答第 31～35 题：In 2010. a federal judge shook America's biotech industry to its core. Companies had won patents for isolated DNA for decades-by 2005 some 20% of human genes were parented. But in March 2010 a judge ruled that genes were unpatentable. Executives were violently agitated. The Biotechnology Industry Organisation (BIO), a trade group, assured members that this was just a “preliminary step” in a longer battle.

A. On July 29th they were relieved, at least temporarily. A federal appeals court overturned the prior decision, ruling that Myriad Genetics could indeed hold patents to two genes that help forecast a woman's risk of breast cancer. The chief executive of Myriad, a company in Utah, said the ruling was a blessing to firms and patients alike.
B. But as companies continue their attempts at personalised medicine, the courts will remain rather busy. The Myriad case itself is probably not over. Critics make three main arguments against gene patents: a gene is a product of nature, so it may not be patented; gene patents suppress innovation rather than reward it; and patents' monopolies restrict access to genetic tests such as Myriad's. A growing number seem to agree. Last year a federal task-force urged reform. for patents related to genetic tests. In October the Department of Justice filed a brief in the Myriad case, arguing that an isolated DNA molecule “is no less a product of nature... than are cotton fibres that have been separated from cotton seeds.”
C. Despite the appeals court's decision, big questions remain unanswered. For example, it is unclear whether the sequencing of a whole genome violates the patents of individual genes within it. The case may yet reach the Supreme Court.
D. AS the industry advances, however, other suits may have an even greater impact. Companies are unlikely to file many more patents for human DNA molecules - most are already patented or in the public domain .firms are now studying how genes interact, looking for correlations that might be used to determine the causes of disease or predict a drug’s efficacy. Companies are eager to win patents for ‘connecting the dots’, explains Hans Sauer, a lawyer for the BIO.
E. Their success may be determined by a suit related to this issue, brought by the Mayo Clinic, which the Supreme Court will hear in its next term. The BIO recently held a convention which included sessions to coach lawyers on the shifting landscape for patents. Each meeting was packed.
F. 第 31 题 It can be learned from paragraph I that the biotech companies would like______
G. their executives to be active
H. judges to rule out gene patenting
I. genes to be patentable
J. the BIO to issue a warning

本文链接：https://www.51ksbd.net/show/8q4wyj.html